Prosecution Insights
Last updated: August 18, 2026

Examiner: GERMAIN, ADAM ADRIEN

Tech Center 1700 • Art Units: 1718 1776 1777

This examiner grants 24% of resolved cases

Performance Statistics

24.5%
Allow Rate
-40.5% vs TC avg
109
Total Applications
-3.6%
Interview Lift
1266
Avg Prosecution Days
Based on 49 resolved cases, 2023–2026

Rejection Statute Breakdown

3.7%
§101 Eligibility
14.5%
§102 Novelty
55.1%
§103 Obviousness
26.0%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18326694 LIFTER FOR A LAUNDRY APPLIANCE THAT INCLUDES AN INTERNAL FILTER FOR REMOVING PET HAIR FROM LAUNDRY BEING PROCESSED Non-Final OA WHIRLPOOL CORPORATION
17933828 Systems and Methods for Gas-Liquid Contactors for Rapid Carbon Capture Non-Final OA The Regents of the University of California
19349993 SWIMMING POOL ROBOT Non-Final OA XINGMAI INNOVATION TECHNOLOGY (SUZHOU) CO., LTD.
17268719 METHOD AND CHROMATOGRAPHY SYSTEM FOR DETERMINING AMOUNT AND PURITY OF A MULTIMERIC PROTEIN Final Rejection REGENERON PHARMACEUTICALS, INC.
18089378 Method of Controlling Filtration Time, Water Purifier and Device Final Rejection Midea Group Co., Ltd.
19230607 ADSORBENT AND METHOD FOR REMOVING PER- AND/OR POLYFLUOROALKYL SUBSTANCES (PFAS) IN WATER MATRICES Final Rejection University of Central Florida Research Foundation, Inc.
17977671 DUAL LUMEN PATIENT LINE SYSTEM AND METHOD HAVING KINK DETECTION Final Rejection BAXTER HEALTHCARE SA
17912702 WATER TREATMENT METHOD, WATER TREATMENT DEVICE AND SLIME INHIBITOR FOR MEMBRANES Non-Final OA ORGANO CORPORATION
18076964 FLUORESCENCE DETECTION OF SULFITE IN WATER TREATMENT APPLICATIONS Final Rejection CHEMTREAT, INC.
18002667 TREATMENT OF NITROGEN COMPOUNDS IN SPENT CAUSTIC Final Rejection LUMMUS TECHNOLOGY LLC
17937341 LIQUID CHROMATOGRAPH Non-Final OA HITACHI HIGH-TECH ANALYSIS CORPORATION
17625655 TEMPERATURE-CONTROLLED PURIFICATION OF GRANULOCYTE-COLONY STIMULATING FACTOR Non-Final OA Tanvex BioPharma USA, Inc.
17618327 Filter Assembly and Container for Collecting a Body Fluid Containing the Same Non-Final OA Fresenius Hemocare Italia S.R.L.

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month